Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alexion Pharmaceuticals Inc.

http://www.alexion.com

Latest From Alexion Pharmaceuticals Inc.

Vertex Spots Potential Bargain Of $60m Entry Into Complement Regulation

Vertex has acquired the full assets to a promising protease-based drug platform from Catalyst, broadening its R&D base once again.

Deals Ophthalmic

ERC Not Giving Up On Glioma Immunotherapy In EU

ERC Belgium has pledged to collect more data to convince the European Medicines Agency that Sitoiganap merits approval. Meanwhile, UGA Biopharma said it would address the agency’s objections over its biosimilar version of eptacog alfa.

Drug Review Regulation

Microbot Medical Hopes To Bring First Disposable Endovascular Robot To US Market

Microbot Medical CEO Harel Gadot said a recent regulatory filing marks an important milestone in his company' efforts to bring the world’s first fully disposable endovascular robot to market.

Innovation Medical Device

Dr Reddy’s Pressing On In Russia, China Approvals Add Spark

Momentum for Dr Reddy’s in China as a string of approvals including for lenalidomide come through, while it appears to be on an even keel in Russia, a market where several foreign firms have cutback activities in the wake of the Ukraine conflict. Will the Indian firm’s Russia strategy payback?

Strategy Sales & Earnings
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Alexion Pharma K.K. (formerly Legend K.K. or Legend Pharma Co., Ltd.) (Japan)
    • AstraZeneca PLC
    • Enobia Pharma Corp.
    • Portola Pharmaceuticals, Inc. (PTLA)
    • Synageva BioPharma Corp.
    • Syntimmune, Inc.
    • Taligen Therapeutics, Inc.
    • Wilson Therapeutics AB
UsernamePublicRestriction

Register